$26,20
▲ +$1,00
(+3,97%)
Vol 85K
Kap. Pasar
$1.5B
ROE
-54,4%
Margin
-52,7%
Beta
1,61
52W
$21–$38
Konsensus Wall Street
18 analis · Apr 20266
Beli Kuat
10
Beli
2
Tahan
0
Jual
0
Jual Kuat
88,9%
Peringkat Beli
Grafik Harga
Saham Serupa
AXGN
AxoGen Inc
$1.5B
OMCL
Omnicell Inc
P/E 102,1
$2.0B
ATEC
Alphatec Holdings Inc
$3.1B
INSP
Inspire Medical Systems Inc
P/E 11,2
$1.6B
ATRC
AtriCure Inc
$2.0B
PRCT
Procept Biorobotics Corp
$1.8B
BFLY
Butterfly Network Inc
$1.3B
TNDM
Tandem Diabetes Care Inc
$1.5B
PLSE
Pulse Biosciences Inc
$930.4M
KMTS
Kestra Medical Technologies Ltd
$1.5B
Pendapatan
Tingkat beat: 100,0%| Kuartal | EPS Estimasi | EPS Aktual | Kejutan |
|---|---|---|---|
| Des 2025 | $0,84 | $0,95 | +$0,11 |
| Sep 2025 | $0,66 | $0,75 | +$0,09 |
| Jun 2025 | $0,73 | $0,79 | +$0,06 |
| Mar 2025 | $0,76 | $0,81 | +$0,05 |
Pendapatan & Laba Kuartalan
| Kuartal | 2024-1… | 2025-0… | 2025-0… | 2025-0… | 2025-1… |
|---|---|---|---|---|---|
| Pendapatan | $561.0M | $558.8M | $564.5M | $548.9M | $575.8M |
| Laba Bersih | -$703.3M | -$56.0M | -$36.7M | -$571.1M | -$520.6M |
Tren Fundamental
| Metrik | 2026-04-12 | 2026-04-17 |
|---|---|---|
| ROE (TTM) | -54.4% | -54.4% |
| P/E (TTM) | — | — |
| Net Margin | -52.7% | -52.7% |
| Gross Margin | 58.2% | 58.2% |
| D/E Ratio | — | — |
| Current Ratio | 2.02 | 2.02 |
Rasio Utama
ROA (TTM)
-26,1%
P/S (TTM)
0,65
P/B
1,0
EPS (TTM)
$-20,72
CF/Share
$1,86
Pertumbuhan Pendapatan 3T
+12,9%
52W High
$37,85
52W Low
$21,00
$21,00
Rentang 52 Minggu
$37,85
Kesehatan Keuangan
Arus Kas Bebas
$32.3M
Utang Bersih
$1.3B
Kas
$36.4M
Total Utang
$1.4B
Per tanggal Des 31, 2025
Як ENOV виглядає на тлі конкурентів у Health Care?
Група порівняння: Peers · Health Care (Peers) · 10 компаній
Оцінка ENOV vs аналоги Health Care
P/E
—
▼
0%
di bawah
rekan
(42,6)
vs Rekan
vs Industri
Nilai wajar
P/S
0,6
▼
84%
di bawah
rekan
(3,9)
vs Rekan
vs Industri
Undervalued
P/B
1,0
▼
80%
di bawah
rekan
(5,1)
vs Rekan
vs Industri
Undervalued
Дивідендна дохідність
—
▼
0%
di bawah
rekan
(1,6%)
vs Rekan
vs Industri
Yield rendah
Прибутковість ENOV vs аналоги Health Care
ROE
-54,4%
▼
289%
di bawah
rekan
(-14,0%)
vs Rekan
vs Industri
Lemah
Net margin
-52,7%
▼
308%
di bawah
rekan
(-12,9%)
vs Rekan
vs Industri
Lemah
Валова маржа
58,2%
▼
5%
di bawah
rekan
(61,4%)
vs Rekan
vs Industri
Sejajar
ROA
-26,1%
▼
148%
di bawah
rekan
(-10,5%)
vs Rekan
vs Industri
Lemah
Фінансове здоровʼя ENOV vs аналоги Health Care
D/E ratio
—
▼
0%
di bawah
rekan
(14,3)
vs Rekan
vs Industri
Utang tinggi
Поточна ліквідність
2,0
▼
36%
di bawah
rekan
(3,2)
vs Rekan
vs Industri
Likuiditas rendah
Beta
1,6
▲
50%
di atas
rekan
(1,1)
vs Rekan
vs Industri
Lebih volatil
Радар фундаменталів ENOV
ENOV
Median rekan
Industri
ENOV прибутковість vs борг
Розмір бульбашки = капіталізація · X = чиста маржа · Y = D/E ratio
ENOV vs аналоги: ключові метрики
Aktivitas Orang Dalam
BullishPembelian
13
$145915
Penjualan
0
ORTIZ CHRISTINE
Director · Mar 31
award
770 shs
ENGERT OLIVER
Officer · Mar 13
purchase
1000 shs
ENGERT OLIVER
Officer · Mar 10
purchase
1000 shs
LANG PATRICIA A
Officer · Mar 09
award
25586 shs
TANDY BRADLEY J
Officer · Mar 09
award
25586 shs
MCDONALD DAMIEN
Chief Executive Officer · Mar 09
award
143923 shs
KLECKNER JOHN
Officer · Mar 09
award
14925 shs
BERRY PHILLIP BENJAMIN BEN
Chief Financial Officer · Mar 09
award
47974 shs
ROSS TERRY D
Officer · Mar 09
award
36247 shs
VOGT LOUIS
Officer · Mar 09
award
36247 shs
Terakhir 90 hari
Imbal Hasil Beli Orang Dalam
ENGERT OLIVER
Mar 13, 2026
$23740
+10,36%
ENGERT OLIVER
Mar 10, 2026
$23930
+9,49%
ENGERT OLIVER
Mar 09, 2026
$41700
+12,01%
ENGERT OLIVER
Mar 04, 2026
$31045
+5,77%
ENGERT OLIVER
Feb 27, 2026
$25500
+2,75%
KLECKNER JOHN
Nov 25, 2025
$74830
-13,59%
MCDONALD DAMIEN
Sep 11, 2025
$199973
-15,4%
TANDY BRADLEY J
Agu 22, 2025
$100512
-16,59%
BERRY PHILLIP BENJAMIN BEN
Agu 20, 2025
$74275
-11,81%
PRYOR DANIEL ALEXIS
Agu 13, 2025
$289000
-9,34%
Pemegang Terbesar
Top 5: 44,9%Blackrock Inc.
15,48%
$217.5M
Vanguard Group Inc
11,19%
$157.2M
American Century Companies …
9,14%
$128.4M
Dimensional Fund Advisors LP
4,83%
$67.9M
Rubric Capital Management LP
4,26%
$59.9M
Per tanggal Des 31, 2025
Berita Terbaru
Apakah Saham Cenovus Energy (CVE) Termasuk Saham AS yang Wajib Dibeli Setelah …
Yahoo Finance · Apr 17
Cenovus Energy Incorporation (CVE) Mendapatkan Peningkatan Outlook Kredit
Yahoo Finance · Apr 04
SpartanNash melaju pesat dengan renovasi toko
Yahoo Finance · Apr 01
Analis di BofA Tetap Waspada terhadap Enovix (ENVX) di Tengah Kesulitan Manufaktur
Yahoo Finance · Mar 22
United Airlines Holdings (UAL) Ekonomi Jangka Panjang Hub Membaik Mengikuti Rencana Renovasi …
Yahoo Finance · Mar 18